Collectively, the dual tumor-targeting feature of the Pt NPs, comprising both passive targeting via the EPR effect and active targeting via albumin/SPARC signaling, makes the Pt NP a promising candidate for NP-mediated drug delivery. This evidence concerns the gene ALB and neoplasm.